Clinical Trial Update: Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on HK-660S for primary sclerosing cholangitis, describing its proposed efficacy and safety with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• HK-660S

Snippet

Sponsor: CuromeBiosciences | Conditions: Primary Sclerosing Cholangitis (PSC) | Phase 2 | Status: NOT_YET_RECRUITING